dc.contributor.author |
Zalloua, Pierre |
|
dc.contributor.author |
Abchee, Antoine |
|
dc.contributor.author |
Shbaklo, Hadia |
|
dc.contributor.author |
Zreik, Tony |
|
dc.contributor.author |
Terwedow, Henry |
|
dc.contributor.author |
Halaby, Georges |
|
dc.contributor.author |
Azar, Sami |
|
dc.date.accessioned |
2015-10-06T07:58:46Z |
|
dc.date.available |
2015-10-06T07:58:46Z |
|
dc.date.copyright |
2004 |
|
dc.date.issued |
2015-10-06 |
|
dc.identifier.issn |
0198-8859 |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10725/2254 |
|
dc.description.abstract |
Type 1 diabetes (T1D) is a complex autoimmune disease. Several genetic loci have been implicated in the susceptibility to this illness. Evaluated was the role of the CTLA4 exon 1 A49G polymorphism and its role as a risk factor for T1D in our population. DNA from 190 patients with T1D and their families and 96 control individuals were genotyped for CTLA4 exon 1 polymorphism and human leukocyte antigen (HLA)–DQB1*0201 and *0302 haplotypes by polymerase chain reaction (PCR) amplification–restriction enzyme analysis and PCR amplification that used sequence-specific primers, respectively. Patients were nonobese and <26 years old. The CTLA4 G allele was found to be more frequently present in patients with T1D (32.4%) as compared with its frequency in control individuals (24.5%). The GG genotype was also significantly higher among patients (12.6%) than in controls (4.2%). χ2 analysis and family-based association studies were performed and suggested the association of CTLA4 exon 1 G polymorphism with T1D (p = 0.0229). Furthermore, in HLA-DQB1*0201–positive patients with T1D, the GG and AA genotypes were higher and lower, respectively, than those found in control individuals. This study suggests that CTLA4 is a candidate susceptibility gene for T1D. |
en_US |
dc.language.iso |
en |
en_US |
dc.title |
Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene |
en_US |
dc.type |
Article |
en_US |
dc.description.version |
Published |
en_US |
dc.author.school |
SOM |
en_US |
dc.author.idnumber |
200300001 |
|
dc.author.idnumber |
200802707 |
|
dc.author.woa |
N/A |
en_US |
dc.author.department |
N/A |
en_US |
dc.description.embargo |
N/A |
en_US |
dc.relation.journal |
Human immunology |
en_US |
dc.journal.volume |
65 |
en_US |
dc.journal.issue |
7 |
en_US |
dc.article.pages |
719-724 |
en_US |
dc.keywords |
Diabetes |
en_US |
dc.keywords |
CTLA4 |
en_US |
dc.keywords |
MHC |
en_US |
dc.keywords |
Early onset |
en_US |
dc.keywords |
SNP |
en_US |
dc.identifier.doi |
http://dx.doi.org/10.1016/j.humimm.2004.04.007 |
en_US |
dc.identifier.ctation |
Zalloua, P. A., Abchee, A., Shbaklo, H., Zreik, T. G., Terwedow, H., Halaby, G., & Azar, S. T. (2004). Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Human immunology, 65(7), 719-724. |
en_US |
dc.author.email |
pierre.zalloua@lau.edu.lb |
|
dc.author.email |
tgzreik@lau.edu.lb |
|
dc.identifier.url |
http://www.sciencedirect.com/science/article/pii/S0198885904001132 |
|
dc.orcid.id |
https://orcid.org/0000-0002-8494-5081 |
|